KoreaMed Synapse

1

Relative efficacy of systemic treatments for patients with relapsed/refractory chronic lymphocytic leukemia: a network meta‑analysis according to 17p deletion/TP53 mutations

Jinchul Kim, Jinhyun Cho, Joo Han Lim, Moon Hee Lee

KMSID: 1516090205 Blood Res. 2025;60:1. Published online 2025 January 2 DOI: http://dx.doi.org/10.1007/s44313-024-00038-2

2

Pseudo Chediak‑Higashi anomaly in a diffuse large B‑cell lymphoma with hemophagocytic lymphohistiocytosis

Biyun Yi, Mengying Zeng

KMSID: 1516090216 Blood Res. 2025;60:2. Published online 2025 January 8 DOI: http://dx.doi.org/10.1007/s44313-024-00052-4

4

Efficacy of bortezomib combined with Hyper-CVAD in adults with relapsed acute lymphoblastic leukemia or positive measurable residual disease; effect of bortezomib in leukemia

Christian Omar Ramos Peñafiel, Daniela Pérez Sámano, Adán Germán Gallardo Rodríguez, Camila Terreros Palacio, Irma Olarte Carrillo, Carlos Martínez Murillo, Gilberto Barranco Lampón, Álvaro Cabrera García, Adolfo Martínez Tovar

KMSID: 1516090223 Blood Res. 2025;60:4. Published online 2025 January 14 DOI: http://dx.doi.org/10.1007/s44313-024-00050-6

5

Post-transplant cyclophosphamide plus anti-thymocyte globulin decreased serum IL-6 levels when compared with post-transplant cyclophosphamide alone after haploidentical hematopoietic stem cell transplantation

Jeong Suk Koh, Myung‑Won Lee, Thi Thuy Duong Pham, Bu Yeon Heo, Suyoung Choi, Sang‑Woo Lee, Wonhyoung Seo, Sora Kang, Seul Bi Lee, Chul Hee Kim, Hyewon Ryu, Hyuk Soo Eun, Hyo‑Jin Lee, Hwan‑Jung Yun, Deog‑Yeon Jo, Ik‑Chan Song

KMSID: 1516090224 Blood Res. 2025;60:5. Published online 2025 January 15 DOI: http://dx.doi.org/10.1007/s44313-024-00049-z

7

Comparing haploidentical transplantation with post-transplantation cyclophosphamide and umbilical cord blood transplantation using targeted busulfan in children and adolescents with hematologic malignancies

Kyung Taek Hong, Bo Kyung Kim, Hong Yul An, Jung Yoon Choi, Sang Hoon Song, Kyung‑Sang Yu, In‑Jin Jang, Hyoung Jin Kang

KMSID: 1516090225 Blood Res. 2025;60:7. Published online 2025 January 23 DOI: http://dx.doi.org/10.1007/s44313-025-00057-7

8

Reversibility of acrocyanosis and improvement of capillaroscopic pattern in a patient with polycythemia vera treated with ruxolitinib: a case report

Angelo Nigro

KMSID: 1516090226 Blood Res. 2025;60:8. Published online 2025 January 30 DOI: http://dx.doi.org/10.1007/s44313-024-00053-3

9

Evidence-based Korean guidelines for the clinical management of multiple myeloma: addressing 12 key clinical questions

Sung-Hoon Jung, Youngil Koh, Min Kyoung Kim, Jin Seok Kim, Joon Ho Moon, Chang-Ki Min, Dok Hyun Yoon, Sung-Soo Yoon, Je-Jung Lee, Chae Moon Hong, Ka-Won Kang, Jihyun Kwon, Kyoung Ha Kim, Dae Sik Kim, Sung Yong Kim, Sung-Hyun Kim, Yu Ri Kim, Young Rok Do, Yeung-Chul Mun, Sung-Soo Park, Young Hoon Park, Ho Jin Shin, Hyeon-Seok Eom, Sang Eun Yoon, Sang Mee Hwang, Won Sik Lee, Myung-won Lee, Jun Ho Yi, Ji Yun Lee, Ji Hyun Lee, Ho Sup Lee, Sung-Nam Lim, Jihyang Lim, Ho-Young Yhim, Yoon Hwan Chang, Jae-Cheol Jo, Jinhyun Cho, Hyungwoo Cho, Yoon Seok Choi, Hee jeong Cho, Ari Ahn, Jong Han Choi, Hyun Jung Kim, Kihyun Kim

KMSID: 1516090227 Blood Res. 2025;60:9. Published online 2025 February 4 DOI: http://dx.doi.org/10.1007/s44313-025-00055-9

10

Real-world effectiveness and safety of rituximab and reduced-dose CHP with polatuzumab vedotin (pola-R-CHP) in patients aged > 80 years with diffuse large B-cell lymphoma: a retrospective analysis

Shuku Sato, Shun Tsunoda, Wataru Kamata, Tomiteru Togano, Yotaro Tamai

KMSID: 1516090206 Blood Res. 2025;60:10. Published online 2025 February 5 DOI: http://dx.doi.org/10.1007/s44313-025-00059-5

11

Is t(11;14) in newly diagnosed multiple myeloma a favorable outcome in the novel agent era?

Ye Li, Jingjing Deng, Yuan Jian, Zhiyao Zhang, Wenming Chen

KMSID: 1516090207 Blood Res. 2025;60:11. Published online 2025 February 6 DOI: http://dx.doi.org/10.1007/s44313-025-00056-8

12

Prognostic factors and treatment outcomes of allogeneic stem cell transplantation in lymphoid malignancy

Hyungsoon Kim, Haerim Chung, Hye Won Kook, Soo-Jeong Kim, Yu Ri Kim, Hyunsoo Cho, June-Won Cheong

KMSID: 1516090208 Blood Res. 2025;60:12. Published online 2025 February 10 DOI: http://dx.doi.org/10.1007/s44313-025-00060-y

13

Rosai-Dorfman disease disguised as BRAF V600E-positive histiocytosis – a diagnostic pitfall

Aishwarya Ravindran, Gaurav Goyal, Diana Morlote, Alexander C. Mackinnon

KMSID: 1516090209 Blood Res. 2025;60:13. Published online 2025 February 28 DOI: http://dx.doi.org/10.1007/s44313-025-00061-x

14

A case of dimethyl sulfoxide‑induced seizure in multiple myeloma

Ho Cheol Jang, Ga‑Young Song, Mihee Kim, Seo‑Yeon Ahn, Jae‑Sook Ahn, Deok‑Hwan Yang, Hyeoung‑Joon Kim, Je‑Jung Lee, Sung‑Hoon Jung

KMSID: 1516090210 Blood Res. 2025;60:14. Published online 2025 March 4 DOI: http://dx.doi.org/10.1007/s44313-025-00063-9

15

Transforming hematological research documentation with large language models: an approach to scientific writing and data analysis

John Jeongseok Yang, Sang‑Hyun Hwang

KMSID: 1516090211 Blood Res. 2025;60:15. Published online 2025 March 6 DOI: http://dx.doi.org/10.1007/s44313-025-00062-w

16

Correspondence: “Association of CD40 gene polymorphisms and immune thrombocytopenic purpura in the adult Egyptian population”

Elsayed Abdelkreem

KMSID: 1516090212 Blood Res. 2025;60:16. Published online 2025 March 7 DOI: http://dx.doi.org/10.1007/s44313-025-00066-6

17

Clonal hematopoiesis: elements associated with clonal expansion and diseases

Gangpyo Ryu, Youngil Koh, Siddhartha Jaiswal, Sung‑soo Yoon

KMSID: 1516090214 Blood Res. 2025;60:17. Published online 2025 March 13 DOI: http://dx.doi.org/10.1007/s44313-025-00065-7

18

Diffuse large B‑cell lymphoma presenting as acute adrenal hemorrhage

Fabio Torres, Uriel Suárez, Paola Pizano

KMSID: 1516090213 Blood Res. 2025;60:18. Published online 2025 March 19 DOI: http://dx.doi.org/10.1007/s44313-025-00064-8

19

Seroprevalence of SARS‑CoV‑2 antibodies in patients with hematological and oncological diseases in early 2024

Louise M. Cremer, Jannik Stemler, Rosanne Sprute, Sebastian Herrmann, Theresa Markus, Jon Salmanton‑García, Lutz Gieselmann, Veronica Di Cristanziano, Henning Gruell, Oliver A. Cornely, Sibylle C. Mellinghoff

KMSID: 1516090215 Blood Res. 2025;60:19. Published online 2025 March 28 DOI: http://dx.doi.org/10.1007/s44313-025-00067-5

20

Clinical features and outcomes of JAK2 unmutated erythrocytosis

Jeong Suk Koh, Wonhyoung Seo, Sora Kang, Myung‑Won Lee, Ik‑Chan Song, Deog‑Yeon Jo

KMSID: 1516090217 Blood Res. 2025;60:20. Published online 2025 March 31 DOI: http://dx.doi.org/10.1007/s44313-025-00072-8

21

Efficacy and safety of thalidomide with hydroxyurea in sickle cell anemia: a quasi‑experimental clinical trial

Priyanka Samal, Anindita Paul, Harshwardhan Bahirat, Ajit Kumar Bishoyi, Venkatarao Epari

KMSID: 1516090218 Blood Res. 2025;60:21. Published online 2025 April 1 DOI: http://dx.doi.org/10.1007/s44313-025-00068-4

22

Frequent association of malignant effusions in plasmablastic lymphoma: a single-institutional experience of nine cases in Taiwan

Bo-Jung Chen, Yu-Ting Kuo, Sheng-Tsung Chang, Khin-Than Win, Shang-Wen Chen, Sheng-Yen Hsiao, Yin-Hsun Feng, Yen-Chuan Hsieh, Shih-Sung Chuang

KMSID: 1516090219 Blood Res. 2025;60:22. Published online 2025 April 7 DOI: http://dx.doi.org/10.1007/s44313-025-00070-w

24

Analysis of hemolysis-associated acute myeloid leukemia genes obtained using weighted gene co-expression network analysis and a Mendelian randomization study

Rui Zhang, Yan Zang, Linguo Wan, Hui Yu, Zhanshan Cha, Haihui Gu

KMSID: 1516090220 Blood Res. 2025;60:24. Published online 2025 April 11 DOI: http://dx.doi.org/10.1007/s44313-025-00073-7

25

Very low-dose vemurafenib maintenance for cardiac Erdheim Chester disease

Abhijeet Kumar Agrawal, Pronamee Borah, P. D. Rath, Rahul Naithani

KMSID: 1516090222 Blood Res. 2025;60:25. Published online 2025 April 11 DOI: http://dx.doi.org/10.1007/s44313-025-00075-5

26

Real-world treatment patterns, outcomes, and economic costs by lines of therapy in patients with newly diagnosed multiple myeloma: a nationwide population-based cohort study in South Korea

Sung‑Soo Park, YoungJu Park, Soomin Yoon, Doik Lee, Jihyeon Jeong, Kihyun Kim

KMSID: 1516090221 Blood Res. 2025;60:26. Published online 2025 April 15 DOI: http://dx.doi.org/10.1007/s44313-025-00069-3